Everolimus plus endocrine therapy beyond CDK4/6 inhibitors progression for HR+ /HER2− advanced breast cancer: a real-world evidence cohortRodrigo Sánchez-Bayona, Miguel Martín, Isabel Echavarría et al.|Breast Cancer Research and Treatment|2024Cited by 21
Abstract P3-01-04: A real-world evidence study of everolimus plus endocrine therapy beyond CDK4/6 inhibitors for HR+/HER2- advanced breast cancerRodrigo Sánchez-Bayona, Eva Ciruelos, Manuel Alva et al.|Cancer Research|2023Cited by 1